News
CILcare to present results on ototoxic side effects of cancer and covid-19 treatments at NF Conference
We are pleased to announce that CILcare's Chief Scientific Officer, Sylvie Pucheu, PhD, will be at the Children Tumour Foundation's NF Conference in Philadelphia on June 19th to give a poster presentation on the ototoxic side effects of cancer and Covid-19 treatments....
Join CILcare at the Inner Ear Therapeutics Disorders Summit in Boston!
For the second year in a row, CILcare will be sponsoring this event dedicated to inner ear therapeutics development to further act towards better treatments and innovation for those suffering from hearing disorders. Upcoming presentation: “Sensorineural Hearing...
Delivery Approaches for Inner Ear Therapies – ARO 2022 Workshop Replay
CILcare is pleased to share the replay of the Translational Delivery Approaches for Inner Ear Therapies workshop organized with CBSET as part of the 45th ARO MidWinter Meeting. Chaired by Professor Peter Steyger, PhD, Director of the Translational Hearing Center at...
Join CILcare and CBSET for a Continuing Education Course on Ototoxicity
We are pleased to announce that CBSET and CILcare will be hosting a Continuing Education session entitled "Best Practices for Successfully Assessing Ototoxicity in Drug Development" on Sunday, March 27th, at 1:15 PM (PST). Hearing loss is a major global health issue...
Best practices for the conduct of preclinical ototoxicity evaluation : Talking Tox Webinar Replay
CILcare is pleased to share the replay of the Talking Tox Webinar that took place as part of ACT's 42nd virtual annual meeting, featuring experts from the FDA, CILcare and CBSET Ototoxicity resulting in inner ear damage is a leading cause of acquired hearing loss...
CILcare publishes new data on noise-induced hidden hearing loss
We are excited to announce that CILcare has released a new publication entitled, "Impulse Noise Induced Hidden Hearing Loss, Hair Cell Ciliary Changes and Oxidative Stress in Mice", in the journal Antioxidants, special issue "Oxidative Stress and Inflammation in...
CILcare will be presenting a workshop with its partner CBSET at the ARO 2022 meeting
We are pleased to announce that CILcare and its partner CBSET are organizing a workshop that will gather renowned experts in the field of inner ear diseases. Recent advances in understanding the mechanisms involved in inner ear diseases have accelerated the...
Upcoming webinar on ototoxicity – 20 January 2022: save the date!
CILcare is pleased to announce that our Global Head of R&D Operations Management, Aurore Marie, will present the latest advances on ototoxicity during the CBSET Talking Tox Webinar as part of ACT's 42nd virtual annual meeting. We are also thrilled to announce the...
